Congress moves to block state contraception bans with federal right to access

What it does

This bill creates a federal statutory right to access contraceptives and for health care providers to supply them, contraception, and related information. It bars federal and state governments from restricting, banning, or singling out contraceptives or contraception services, and allows individuals and providers to sue in federal court to enforce the right, with attorney's fees awarded to prevailing plaintiffs.

Why we flagged it

The bill's core mechanism is a federal statutory right to contraception and a private right of action to enforce it against state restrictions. It is a rights-expansion and anti-restriction measure, not a subsidy, carve-out, or deregulation.

What the text implies

• The bill's preemption language (Section 6) is broad and may override state laws not explicitly about contraception if they have the effect of restricting access—e.g., pharmacy licensing rules, insurance mandates, or facility regulations. Courts will need to interpret 'impedes access' and 'singles out' in practice.
• The 'clear and convincing evidence' standard in Section 5(b) is a high bar for states to defend restrictions, shifting the burden substantially toward federal protection and away from state police power.
• The bill does not mandate insurance coverage or public funding for contraceptives—it only protects the right to obtain and provide them. Coverage mandates remain governed by existing law (ACA, Medicaid), so access may still be limited by cost or insurance design.
• Private right of action with attorney's fees (Section 8) may generate significant litigation against states with restrictive laws, potentially creating a chilling effect on state-level contraception restrictions even before courts rule on constitutionality.
• The bill's definition of contraception is broad and includes fertility-awareness methods and sterilization, which may create tension with state laws regulating informed consent for sterilization or defining certain methods as abortifacients.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

The bill expands access to contraception by blocking state and federal restrictions, protecting patient choice and provider autonomy, and creating enforceable remedies. It directly benefits individuals seeking contraception and providers offering it, with no offsetting cost to ordinary citizens.

Who stands to gain

• pharmaceutical manufacturers (contraceptive drugs and devices)
• medical device companies (IUDs, implants, barrier methods)
• health care providers (expanded patient access and service demand)
• health insurance companies (potential increase in contraceptive claims under existing coverage manda

Named in the bill

U.S. Department of Health and Human Services, FDA (Food and Drug Administration), State governments, Health care providers (physicians, nurses, pharmacists, nurse practitioners, physician assistants, c, Patients and individuals, Bayer (BMY), Genmyth (GH), Pfizer (PFE), DaVita (DVA), Johnson & Johnson (JNJ)

Where it stands

41 cosponsors: 40 Democrats, 1 Independents.

• Feb 5, 2025 — Introduced · Congress.gov: “Introduced in Senate”
• Feb 5, 2025 — Referred to Senate Committee on Health, Education, Labor, and Pensions · Congress.gov: “Read twice and referred to the Committee on Health, Education, Labor, and Pensions”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

7 lobbying clients named this bill on 12 disclosure filings across 2 quarters, Dec 2025 to Jun 2026. Those filings disclosed $3,061,943 in lobbying spend. A filing names 60 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 86% of bills with at least one filing.

Ed Markey, the sponsor, reported $658,450 in PAC receipts in the 2026 cycle.

• American Academy of Family Physicians — $1,715,904 on 2 filings
• Planned Parenthood Federation of America Inc — $652,972 on 1 filing
• Human Rights Campaign — $439,908 on 2 filings
• Hadassah, the Women's Zionist Organization of America, Inc. — $120,000 on 2 filings
• Planned Parenthood Action Fund Inc — $79,708 on 1 filing

Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.